GSK discontinues Sandocal 1000 effervescent tablets

GSK confirm the discontinuation of Sandocal 1000 effervescent tablets due to commercial reasons. There are currently no plans to restore the product.

Source: Society for Endocrinology - February 26, 2020 Category: Endocrinology Source Type: news